The growth of
the global cholesterol test market is driven by various factors such as the
increasing prevalence of cardiovascular diseases & obesity, government
initiatives to improve the quality of clinical diagnostics. However, the lack
of a skilled workforce is projected to hamper the growth of the global
cholesterol test market.
The cholesterol test market is expected to reach USD
11,342.47 Million by 2030 at 8.20% CAGR during the forecast period 2022-2030
According to
recent studies, cardiovascular disease is the leading global cause of death,
accounting for more than 17.6 million deaths per year in 2016, a number that is
expected to grow to more than 23.6 million by 2030. The increasing incidences
of obesity are driving the growth of the cholesterol test market. For instance,
in 2016, 39% of adults aged 18 years and over (39% of men and 40% of women) were
overweight. Globally, about 13% of the world's adult population was obese in
2016. The worldwide prevalence of obesity nearly tripled between 1975 and 2016,
Major Key
Players:
Some of the Cholesterol Test Market Players are Quest Diagnostics
Incorporated, Cell Biolabs, Inc., Clinical Reference Laboratory, Inc.,
Laboratory Corporation of America Holdings, Randox Laboratories Ltd., Thermo
Fisher Scientific, PTS DIAGNOSTICS, Alere Inc., F. Hoffmann-La Roche AG, and
Eurofins Scientific.
Segment Analysis
The Global Cholesterol Test Market has been segmented based on
Product Type, Test Type, Distribution Channel, and End User.
The point of care cholesterol testing market, based
on product type, has been divided into test kits and test strips. The test kits
segment is likely to be the largest segment during the review period due to the
growing awareness and adoption of preventive healthcare.
The market, based on test type, has been divided into total
cholesterol test, high-density lipoprotein (HDL) cholesterol, low-density
lipoprotein (LDL) cholesterol, and triglycerides/VLDL cholesterol test. The
total cholesterol test segment is likely to be the largest segment during the
review period due to the growing importance of the test. A complete
cholesterol test includes the calculation of four types of fats (lipids) in
blood.
The market, based on distribution channel, has been divided
into over the counter and prescription-based. The prescription-based segment is
likely to be the largest segment during the review period.
The global cholesterol test market has been
segmented, based on end user, into hospitals & clinics, homecare,
diagnostic centers, and others. The hospitals & clinics segment is expected
to hold the majority share of the market owing to the rising in visits of
patients in the hospitals and clinics.
Regional
Analysis
The market has been divided, by
region, into the Americas, Europe, Asia-Pacific, and the Middle East &
Africa. The Americas is expected to be the largest market owing to the rising
per capita healthcare expenditure. The cholesterol test market in the Americas
has further been branched into North America and Latin America, with the North
American market divided into the US and Canada. As per recent studies, most
(55.4%) of the Canadian adult population categorized as overweight (34.2%) or
obese (21.2%). Furthermore, the prevalence of obese classes I, II, and III will
increase to 14.8%, 4.4% and 2.0%, respectively.
The European cholesterol test
market has been categorized as Western Europe and Eastern Europe. The Western
European market has further been classified as Germany, France, the UK, Italy,
Spain, and the rest of Western Europe. According to WHO, the obesity rate in
Germany is 23.7% which means that Germany has one of the highest obesity rates
in Europe, but is still behind the UK, which has a rate of 26.2 %.
The cholesterol test market in
Asia-Pacific has been segmented into Japan, China, India, South Korea,
Australia, and the rest of Asia-Pacific. Due to the increasing prevalence of
cardiovascular diseases and obesity, the market in Asia-Pacific is expected to
be the fastest-growing. According to WHO, Obesity in China is a major health
concern with overall rates of obesity between 5% and 6% for the country, but
greater than 20% in some cities where fast food is popular. The cholesterol
test market in the Middle East & Africa has been divided into the Middle
East and Africa.
About Market Research
Future
At Market Research Future (MRFR), we enable our customers
to unravel the complexity of various industries through our Cooked Research
Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact us:
Market Research Future
(part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
